Gujarat Kidney IPO logo

Gujarat Kidney IPO

Listed

GKSL

Mainboard NSE,BSE Healthcare

Gujarat Kidney IPO, a Mainboard IPO was listed on the exchange on December 30, 2025. The price band is set between ₹108 –114 , with a face value of ₹2 . Retail investors can apply with a minimum of 1 lot, each comprising 128 shares — amounting to ₹14,592 at the upper price.

Gujarat Kidney IPO has been successfully listed on the exchange. Track the listing performance, current stock price, and post-listing trends. This information is for education only—not investment advice.

Gujarat Kidney IPO MAINBOARD Important Dates

Get important updates regarding Gujarat Kidney IPO MAINBOARD tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates. Dates are updated as soon as they are announced.

IPO Timeline

Open Date

Dec 22

Close Date

Dec 24

Allotment

Dec 26

Listing

Dec 30

Price Band & Investment Details

Issue Size

22,000,000 shares
(aggregating up to ₹250.80 Cr)

Issue Price

₹108 – ₹114

Face Value

₹2/share

Market Lot

128 shares

Retail Min Investment

₹14,592

Listing At

NSE,BSE

Sale Type

fresh issue

Issue Type

book building

Gujarat Kidney IPO IPO Grey Market Premium (GMP) - Live Rates & Current Status

Last updated: 1 month ago

Current GMP
₹1.5
Previous GMP
₹1.5

Gujarat Kidney IPO IPO GMP Historical Data - Complete Track Record

Date IPO Issue Price (₹) GMP (₹) Est. Listing Price (₹) Est. Profit Amount (₹) Est. Profit % Last Updated
30 Dec 2025 Latest ₹114 ₹1.5 ₹115.5 ₹1.5
1.32%
12:00 PM
29 Dec 2025 ₹114 ₹1.5 ₹115.5 ₹1.5
1.32%
12:00 PM
28 Dec 2025 ₹114 ₹0 ₹114 ₹0
0%
12:00 PM
27 Dec 2025 ₹114 ₹0 ₹114 ₹0
0%
12:00 PM
26 Dec 2025 ₹114 ₹0 ₹114 ₹0
0%
12:00 PM
25 Dec 2025 ₹114 ₹0 ₹114 ₹0
0%
12:00 PM
24 Dec 2025 ₹114 ₹0 ₹114 ₹0
0%
12:00 PM
23 Dec 2025 ₹114 ₹4 ₹118 ₹4
3.51%
12:00 PM
22 Dec 2025 ₹114 ₹4 ₹118 ₹4
3.51%
8:00 PM
22 Dec 2025 ₹114 ₹7 ₹121 ₹7
6.14%
12:00 PM
21 Dec 2025 ₹114 ₹7 ₹121 ₹7
6.14%
12:00 PM
20 Dec 2025 ₹114 ₹7 ₹121 ₹7
6.14%
12:00 PM
19 Dec 2025 ₹114 ₹8 ₹122 ₹8
7.02%
12:00 PM
18 Dec 2025 ₹114 ₹10 ₹124 ₹10
8.77%
12:00 PM
17 Dec 2025 ₹114 ₹0 ₹114 ₹0
0%
12:00 PM
16 Dec 2025 ₹114 ₹0 ₹114 ₹0
0%
12:00 PM
15 Dec 2025 ₹114 ₹0 ₹114 ₹0
0%
12:00 PM

Subscription (Latest Snapshot)

View Detailed Subscription

Latest snapshot: Jan 04, 2026

Category Subscribed (x)
QIB 0.89x
NII 4.14x
bNII (bids above ₹10L) 3.77x
sNII (bids below ₹10L) 4.88x
Retail Investors 14.22x
Total 3.92x

Registrar

Registrar
MUFG Intime India Pvt.Ltd
Registrar Phone
+91-22-4918 6270
Registrar Email
gujaratkidney.ipo@linkintime.co.in
Registrar Address
C-101, 1st Floor, 247 Park, Lal Bahadur Shastri Marg, Vikhroli (West), Mumbai - 400 083, India

Promoter Holding

Dr. Pragnesh Yashwantsinh Bharpoda, Dr. Bhartiben Pragnesh Bharpoda, Dr. Yashwantsingh Motisinh Bharpoda and Anitaben Yashwantsinh Bharpoda are the company promoters.

Promoter Holding Pre Issue
99.10%
Promoter Holding Post Issue
71.45%

Gujarat Kidney IPO Investment Limits

IPO investment limits, also referred to as application limits or bidding limits, define the minimum and maximum number of shares, lots, and investment amount that investors can apply for in an IPO based on their category (Retail, HNI, or Institutional). These limits are calculated as per SEBI guidelines and help ensure fair distribution of shares. Retail investors typically have lower minimum and maximum limits compared to High Net Worth Individuals (HNI) and Non-Institutional Investors (NII). Understanding IPO application limits is essential for investors to determine how much they can invest, calculate the number of lots they can apply for, and plan their investment strategy accordingly. The investment limits table shows the lot size, number of shares, and total amount in rupees for each investor category.

Category Lots Shares Amount (₹)
Retail (Min) 1 128 ₹14,592
Retail (Max) 13 1,664 ₹189,696
S-HNI (Min) 14 1,792 ₹204,288
S-HNI (Max) 68 8,704 ₹992,256
B-HNI (Min) 69 8,832 ₹1,006,848

IPO Reservation

The IPO reservation structure, also known as share allocation breakdown, details how the total issue size is distributed among different investor categories as mandated by SEBI (Securities and Exchange Board of India) regulations. This reservation table shows the exact percentage and number of shares allocated to Qualified Institutional Buyers (QIB), Retail Individual Investors (RII), High Net Worth Individuals (HNI), Non-Institutional Investors (NII), and other reserved categories like employees and shareholders. Understanding IPO reservation percentages is crucial for investors to evaluate their probability of share allotment, as each category has different subscription levels and competition. The maximum allottees column indicates the cap on the number of investors who can receive shares in each category, helping you assess the likelihood of getting an allotment based on your investor category.

Category Shares Offered Maximum Allottees
QIB Shares Offered 16,500,000 (75.00%) NA
Anchor Investor Shares Offered
8,773,120 (39.88%) NA
QIB (Ex. Anchor) Shares Offered
7,726,880 (35.12%) NA
NII (HNI) Shares Offered 3,300,000 (15.00%) NA
bNII > ₹10L
2,200,000 (10.00%) NA
sNII < ₹10L
1,100,000 (5.00%) NA
Retail Shares Offered 2,200,000 (10.00%) NA
Total Shares Offered 22,000,000 (100.00%)

Gujarat Kidney & Super Speciality Overview

Incorporated in December 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) is a regional multispeciality healthcare provider focused on secondary and tertiary care in central Gujarat. It operates 6 hospitals and 3 in-house pharmacies across Vadodara, Godhra, Bharuch, Borsad, and Anand, with a total bed capacity of 400 (operational: 250). Services span general medicine, surgery, orthopaedics, urology, cardiology, nephrology, neurology, and more, supported by in-house diagnostics.

Growth: Revenue surged from ₹0.79 Cr in FY22 to ₹4.77 Cr in FY24 and ₹18.67 Cr in H1 FY25, driven by strategic acquisitions (e.g., Raj Palmland Hospital) and expansion plans using IPO proceeds for new facilities and equipment.

Key Strengths: Strong regional presence in underserved markets, high operational efficiency (EBITDA margin ~41-50%), experienced team (322 employees, including 53 consultants and 138 nurses), low debt (D/E ratio 0.18), and focus on affordable, quality care.

Founded In
2019
Managing Director
Dr. Pragnesh Yashwantsinh Bharpoda
Headquarters
Plot No. 1, City Survey No. 1537/A, Jetalpur Road, Gokak Mill Compound, Alkapuri, Vadodara - 390020, Gujarat, India
Industry
Healthcare

Financial Summary (₹ in Crores)

Particulars FY 2023 FY 2024 FY 2025
Total Revenue 0 5.48 40.4
Profit After Tax (PAT) -0.01 1.71 9.5
Net Worth 0.37 10.8 25.71

Frequently Asked Questions

What are the Gujarat Kidney IPO dates?

The Gujarat Kidney IPO is expected to open in December, 2025, subject to SEBI approval. Final dates will be updated once announced officially.

What is the price band of Gujarat Kidney IPO?

The price band for Gujarat Kidney IPO is ₹108.00 - ₹114.00 per share.

What is the GMP today for Gujarat Kidney IPO?

As per market sources, Gujarat Kidney IPO GMP is currently ₹1.50. GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.

How much subscription has happened for Gujarat Kidney IPO?

The subscription status for Gujarat Kidney IPO stands at 3.92x overall.

When is the Gujarat Kidney IPO listing date?

The listing date for Gujarat Kidney IPO is December 30, 2025.

Community Discussion

0 Comments

No comments yet. Be the first to comment!

You may also like